DESIRIAL® is the first antioxidant hyaluronic acid based gel specifically formulated to preserve women’s intimate health.
Entirely dedicated to women’s intimate health, DESIRIAL® viscosupplement solution developed by Laboratoires VIVACY® opens new treatment options in Gynecology and Intimate Plastic Surgery.
As many as 80% of women entering menopause are affected by vaginal dryness and about 50% of women completing menopause continue to experience vaginal dryness.
Vaginal and/or vulvar dryness may affect women at any period of their lives, whether it is iatrogenic in origin (e.g. isotretinoin, tricyclic antidepressants, neuroleptics, etc.), or linked to menopause, particularly in the absence of Hormone Replacement Therapy (HRT).
During menopause, there is a decrease of estrogen secretion, which has an effect on fibroblasts, and leads to progressive hypotrophy of the dermis with flattening of the dermal-epidermal junction:
As a result, skin dryness, loss of elasticity, flaccidity and fragility appear. Estrogen levels drop (related to menopause) leads to labia majora hypotrophy, characterized also by vulvar dryness.
Injection of cross-linked hyaluronic acid DESIRIAL® into the dermis of the labium can help rehydrate, biostimulate and restore fibroblast activity to maintain proper functioning of the female genital tissues.
DESIRIAL®, Medical Device – Class III – CE Marking No. 0344.
Injection is a medical procedure that requires experience and knowledge.
Consult your doctor (plastic surgeon, gynaecologist, physician who has received specific training)
and read carefully the leaflet supplied with each product.